Share it:
DistilNFO Healthcare M & A
Healthcare M & A Advisory

Weekly Top Stories

Mon, 02 Jul 2018
1. Amazon buys PillPack, an online pharmacy, for just under $1B
2. Thermo Fisher Scientific Signs Agreement to Acquire Gatan from Roper Technologies
3. Sanofi, Advent Finally Shake Hands On $2.2B European Generics Sale
4. Repligen Merging with Spectrum Labs in $359M Deal
5. Stryker to fight surgical fire hazards with SafeAir acquisition
6. Repligen Announces Agreement with Navigo Proteins for the Exclusive Co-Development of Next Generation Affinity Ligands
7. Roche buys out Foundation Med in $2.4B bet on targeted cancer treatment
8. Bayer acquires Monsanto
9. GE to spin off its healthcare unit and divest Baker Hughes’ interests
10. Novartis announces widely expected Alcon spinoff, plus $5B share buyback
About Ed Francis
DistilNFO's Executive Editor & Senior Industry Strategist.
Ed is the National Life Sciences Practice lead for West Monroe Partners & has more than 20 years of management consulting experience guiding some of the industry’s most prominent organizations.
Subscribe to the Newsletter Here
A week after appointing a CEO for its healthcare joint venture with Berkshire Hathaway and JPMorgan, Amazon today announced an acquisition that underscores how it also hopes to have a more direct — and more commercial — role in the worl...
Share: email linkedin twitter facebook
Thermo Fisher Scientific Inc., the world leader in serving science, and Roper Technologies, Inc., a leading diversified technology company, today announced that they have entered into a definitive agreement under which Thermo Fisher will ac...
Share: email linkedin twitter facebook
It’s official: Sanofi is finally ready to unload its European generics business. More than two months after disclosing that they were in exclusive talks, the French drugmaker and buyer Advent International have ironed out the details on a...
Share: email linkedin twitter facebook
Repligen said today it plans to merge with privately-held Spectrum Laboratories, in an approximately $359 million deal that Repligen said will accelerate the growth of its filtration business and enhance its position as a leading developer ...
Share: email linkedin twitter facebook
Stryker Corp. agreed to acquire Swiss medical device company SafeAir AG, The Daily Times reports. SafeAir designs, develops and manufactures surgical smoke evacuation solutions to reduce staff and patient exposure to hazards associated with...
Share: email linkedin twitter facebook
Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, today announced an agreement with Navigo Proteins GmbH for the advancement of exclusive novel affinity ligands used in monoclonal antibody and non...
Share: email linkedin twitter facebook
Dive Brief: Swiss pharma Roche will pay $2.4 billion to acquire the rest of Foundation Medicine that it doesn’t already own, advancing its efforts to develop treatments targeted to the molecular make-up of a patient’s cancer. Ro...
Share: email linkedin twitter facebook
The U.S. Department of Justice approved the acquisition of Monsanto by Bayer. They are two of the largest agricultural companies in the world. As of June 7 Bayer is the sole owner. According to Monsanto, its stock will no longer be traded o...
Share: email linkedin twitter facebook
General Electric on Tuesday announced that it will spin off its healthcare business unit and let go of its stake in Baker Hughes, its publicly traded oil-services company. GE will reportedly be focusing on power plants, jet engines, and ren...
Share: email linkedin twitter facebook
When Novartis CEO Vas Narasimhan was asked during the company’s first-quarter earnings conference call in April what he planned to do with the long-struggling eye unit Alcon, he said he wanted to make the decision next year “from a posi...
Share: email linkedin twitter facebook

Advertise with us

We Reach Quarter Million Decision Makers in:
Healthcare | IT | Retail | Industrial
Advertise with us and reach the right audience.

Contact Us

5760 Legacy Dr,
ste B3-405,
Plano TX 75024
+1 469-270-3311
advertise@distilnfo.com
Copyright 2018. All Rights Reserved. DistilNFO.
View in browser | Unsubscribe